The largest database of trusted experimental protocols

7 protocols using isrib

1

Myogenic Differentiation in C2C12 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A mouse myoblast cell line, C2C12, was cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum at 37°C under 5% CO2.
Myogenic differentiation was induced by replacing the medium with the differentiation medium, DMEM supplemented with 2% horse serum. C2C12 myoblasts were transfected with 50 nM of Stealth RNAi (Thermo Fisher Scientific, Waltham, MA, USA) using Lipofectamine 3000 (Thermo Fisher Scientific) according to the manufacturer's protocol.
The following siRNAs were used: Stealth RNAi siRNA negative control (Negative Control, Med GC, Thermo Fisher Scientific), Stealth RNAi for Myoparr, and Stealth RNAi siRNAs specific for hnRNPK (MSS205172 and MSS205173, Thermo Fisher Scientific). The siRNA sequences are listed in Supplemental Table 1. At 24 h after siRNA transfection, myogenic differentiation was induced. At 24 h or 72 h after differentiation induction, cells were collected for the analysis of RNAs and proteins. For ISRIB treatment, the differentiation medium was added either with or without 1 µM ISRIB (Cayman Chemical Company, Ann Arbor, MI, USA).
+ Open protocol
+ Expand
2

Cellular stress response regulation assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
24S-OHC [52 (link)] was dissolved in EtOH (Wako, Osaka, Japan). F12511 was the generous gift of Kowa (Aichi, Japan). Thapsigargin and CHX were purchased from Wako (Osaka, Japan). GSK2606414 and ISRIB were from Cayman Chemical (Ann Arbor, MI, USA). GCN2iB was from MedChemExpress (Monmouth Junction, NJ, USA). Thapsigargin, GSK2606414, CHX, and ISRIB were dissolved in dimethyl sulfoxide (DMSO; Wako). The following antibodies were from commercial sources: anti-PERK (Cat# 3192), anti-phospho-eIF2α (Cat# 3398), anti-eIF2α (Cat# 5324), and anti-GCN2 (Cat# 3302) were from Cell Signaling (Danvers, MA, USA); anti-β-actin (Cat# A5441) was from Sigma-Aldrich (St. Louis, MO, USA); anti-TIA1 (Cat# 12133-2-AP), anti-ATF4 (Cat# 10835-1-AP), and anti-TDP-43 (Cat# 12782-2-AP) were all from Proteintech (Chicago, IL, USA); anti-G3BP1 (Cat# 611126) was from BD Biosciences (Franklin Lakes, NJ, USA); anti-phospho-GCN2 (Cat# ab75836) was from Abcam (Cambridge, UK); and anti-puromycin (Cat# MABE343) was from Merck Millipore (Burlington, MA, USA); All other chemicals, of analytical grade, were obtained from Sigma-Aldrich or Wako.
+ Open protocol
+ Expand
3

Intravitreal ISRIB Injection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The intravitreal injections were performed as described [51 (link)] with the following modifications. Immediately after the laser coagulation, 9.0 pg or 9.0 ng of ISRIB (Cayman Chemical, Ann Arbor, MI, USA) in 2 µL [10 nM or 10 µM, dissolved in phosphate-buffered saline (PBS) containing 0.1% dimethyl sulfoxide (DMSO)] was injected into the vitreous cavity with a Hamilton glass syringe (701N; Hamilton Co., Reno, NV, USA) fitted with a 34-G nanopass needle (Terumo, Tokyo, Japan). Then, 5 µL of 0.01% levofloxacin ophthalmic solution (Santen Pharmaceuticals Co., Ltd., Osaka, Japan) was applied topically.
+ Open protocol
+ Expand
4

Chemical Inhibitor Screening Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tunicamycin (TM) and thapsigargin (TG) were obtained from Fujifilm-Wako (Osaka, Japan). GSK2656157 and ISRIB were obtained from Cayman Chemical (Ann Arbor, MI, USA). All other chemicals were obtained from Sigma.
+ Open protocol
+ Expand
5

Macrophage Polarization and Tumor Co-culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow cells were differentiated in the presence of recombinant mouse M-CSF (20 ng/ml; PeproTech) in complete medium (RPMI 1640 containing 10 mM glucose, 2 mM L-glutamine, 100 U/mL of penicillin/streptomycin and 10% FBS) for 7 days. Fresh complete medium with M-CSF was supplemented on day 6 prior to use. Day 7 macrophages were washed and variously stimulated with IL-4 (20 ng/ml; PeproTech) or LPS (20 ng/ml; Sigma-Aldrich) plus IFNγ (50 ng/ml; PeproTech) in the absence or presence of 5 μM GSK2656157 (Cayman Chemical), 30 μM CBR-5884 (Cayman Chemical), or 5 μM ISRIB (Cayman Chemical). Macrophages were harvested after 24 h and analyzed by flow cytometry for the expression of M2 or M1 activation. For tumor co-culture experiments, macrophages and tumor cells were collected on day 7. Tumor cells were plated at a density of 5-6 x 105 in a 12-well plate for at least 1 h prior to addition of macrophages. Once tumor cells were attached, 2 x 105 macrophages were added to each well for 72 h. For some experiments, macrophages were cultured with IL-4 in the presence of absence of 1 mM dimethyl-α-KG (dm-KG; Sigma-Aldrich) or 25 μM GSK-J4 (Selleck Chem) for 6 h, and cells were harvested for the further experiments as indicated.
+ Open protocol
+ Expand
6

Laser-Induced Retinal Injury Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Timolol maleate 0.5%, latanoprost 0.005%, and vehicle solutions were kind gifts from Nitto Medic Co. Ltd. (Toyama, Japan), all of which were administered by eye drop (5 µl) immediately and at 3, 6, 12, and 18 h after laser irradiation. In another independent experiment, an integrated stress response inhibitor (ISRIB; 9 ng/2 µl; Cayman Chemical, Ann Arbor, MI) was injected (2 μl) into the vitreous body of the right eye immediately after laser irradiation using a sterile 34-gauge needle (Terumo, Tokyo, Japan) attached to a Hamilton glass syringe (701 N; Hamilton Co., Reno, NV). For controls, mice were IV injected with 2 μl of 0.01 M PBS into the right eye, after which 0.5% levofloxacin ophthalmic solution (Santen Pharmaceuticals Co., Ltd.) was applied topically to the treated eyes.
+ Open protocol
+ Expand
7

Investigating ISR Modulation in HeLa Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells were plated onto a 6-well plate in DMEM culture media supplemented with 10% FBS and penicillin-streptomycin and ISRIB (200 nM) (R and D Systems, cat # 5284/10). Minocycline (100 μM), thapsigargin (200 nM) (Cayman Chemical, cat # 10522) or different combinations of the three were added to 70% confluent cells and incubated for 3 hr (ISRIB and/or thapsigargin-treated samples) or 6 hr (Minocycline-treated samples). 35S incorporation was measured using the protocol described above (35S incorporation).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!